Molecular networks underlying cannabinoid signaling in skeletal muscle plasticity

Sebastiaan Dalle,Moniek Schouten,Gitte Meeus,Lotte Slagmolen,Katrien Koppo
DOI: https://doi.org/10.1002/jcp.30837
2022-07-22
Journal of Cellular Physiology
Abstract:Receptor‐dependent and ‐independent effects of cannabinoids on skeletal muscle metabolism (e.g., substrate oxidation and mitochondrial biogenesis), muscle growth (e.g., protein synthesis via mTORC1), and regenerative capacity (e.g., via regulation of satellite cell growth and macrophage polarization) have therapeutic value to treat muscle degenerative conditions such as sarcopenia and cachexia. The cannabinoid system is ubiquitously present and is classically considered to engage in neural and immunity processes. Yet, the role of the cannabinoid system in the whole body and tissue metabolism via central and peripheral mechanisms is increasingly recognized. The present review provides insights in (i) how cannabinoid signaling is regulated via receptor‐independent and ‐dependent mechanisms and (ii) how these signaling cascades (might) affect skeletal muscle plasticity and physiology. Receptor‐independent mechanisms include endocannabinoid metabolism to eicosanoids and the regulation of ion channels. Alternatively, endocannabinoids can act as ligands for different classic (cannabinoid receptor 1 [CB1], CB2) and/or alternative (e.g., TRPV1, GPR55) cannabinoid receptors with a unique affinity, specificity, and intracellular signaling cascade (often tissue‐specific). Antagonism of CB1 might hold clues to improve oxidative (mitochondrial) metabolism, insulin sensitivity, satellite cell growth, and muscle anabolism, whereas CB2 agonism might be a promising way to stimulate muscle metabolism and muscle cell growth. Besides, CB2 ameliorates muscle regeneration via macrophage polarization toward an anti‐inflammatory phenotype, induction of MyoD and myogenin expression and antifibrotic mechanisms. Also TRPV1 and GPR55 contribute to the regulation of muscle growth and metabolism. Future studies should reveal how the cannabinoid system can be targeted to improve muscle quantity and/or quality in conditions such as ageing, disease, disuse, and metabolic dysregulation, taking into account challenges that are inherent to modulation of the cannabinoid system, such as central and peripheral side effects.
cell biology,physiology
What problem does this paper attempt to address?